Search PubMed⌕ Search

SEARCH · Search PubMed

Results for “throwing”

Search indexed PubMed citations on genomics, clinical trials, systematic reviews and public health. Explore titles, authors and supplied subject terms, then open the PubMed record.

Quote a phrase for an exact phrase match. Source license links do not imply unrestricted reuse.

At least 739 records · Page 41Linked to original sources
PubMed1993

Nature's medicinal bounty: don't throw it away.

Plant-derived drugs have an important place in both traditional and modern medicine. For this reason a special effort to maintain the great diversity of plant species would undoubtedly help to alleviate human suffering in the long term. Proven agroindustrial technologies should be applied to the cultivation and processing of medicinal plants and the manufacture of herbal medicines.

Humans↗
PubMedDate not supplied

Throw the crutches away ... your career depends on it!

NAON and Rhône-Poulenc Rorer have joined together to establish the Professional Development Initiative (PDI): a comprehensive endeavor to better position orthopaedic nurses for their future. Central to the theme of this initiative is the development of self-esteem and self-empowerment strategies that can be used on a daily basis. As part of the PDI, a series of six articles, beginning with this issue, will appear in Orthopaedic Nursing. Each article will present practical, easily definable skills on change management, career development, networking, resume writing and interviewing, and mentoring. All are critical elements designed to help the orthopaedic nurse redefine career goals and increase professional as well as personal growth. The purpose of this first article is to briefly introduce the five elements and encourage you to learn more about each of them as they are presented in upcoming issues.

Career Mobility↗
PubMed1996

Use of the newer antiarrhythmic drugs in patients with supraventricular tachyarrhythmias: let's not throw out the baby with the bath water.

Although recent advances have expanded the therapeutic choices for patients with supraventricular tachyarrhythmias, most of these patients will still require either short or long term treatment with antiarrhythmic drugs. Unfortunately, some practitioners have reacted to recent reports emphasizing the hazards of antiarrhythmic drug therapies by adopting an attitude of avoidance of these therapies. Although critical analyses of available data indicate that many antiarrhythmic drugs may have an unfavourable risk-benefit balance in patients with low risk arrhythmias who also have atherosclerotic heart disease and/or congestive heart failure, the same cannot be said for patients with high risk arrhythmias, for patients without atherosclerotic heart disease or congestive heart failure, or for patients whose symptoms require antiarrhythmic therapy to prevent physical and emotional disability despite a small risk of therapy. These patients are not benefits by the prevalent nihilistic attitude of antiarrhythmic drug avoidance. The purpose of this review is to provide an electrophysiologic background for the rational selection of antiarrhythmic drug therapy for patients with supraventricular tachyarrhythmias with an accent of the newer agents that have been demonstrated to be useful for this purpose.

Anti-Arrhythmia Agents↗